SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?


To: Archie Meeties who wrote (4466)6/22/2020 12:10:57 AM
From: i-node1 Recommendation

Recommended By
Paul Smith

  Read Replies (1) | Respond to of 22884
 
Sure we do. “We” were all over it when a couple ophthalmologists at VA did a bogus study (that wasn’t).

Surely, you’re not claiming that studies performed outside a hospital by a sole practitioner are without substance.

He said his study would be available in the next couple weeks so shouldn’t we give him the benefit of the doubt?

That being said there are some more credible studies (than those previously accepted) showing success by simply adding Zinc.

trtworld.com

medrxiv.org

Not to mention too many governments around the world who are using HCQ+Zinc.

Why would you oppose a physician today presecribing it for his patient? It is not like you have anything else to offer.



To: Archie Meeties who wrote (4466)6/22/2020 10:06:38 PM
From: Investor2  Respond to of 22884
 
Study in India shows health care workers performing intubation had a 4.33 odds ratio of getting infected with Covid-19, unless they were taking HCQ, in which case the odds ratio was only 0.44.




To: Archie Meeties who wrote (4466)6/22/2020 10:10:39 PM
From: Investor2  Respond to of 22884
 
despite the drug’s potentially dangerous side effects
Here is a quote taken from the conclusion of a report prepared by the World Health Organization in 2017, before the recent popularity of the U.S. press and politicians to bash the use of HCQ for treating Covid-19.

"Despite hundreds of millions of doses administered in the treatment of malaria, there have been
no reports of sudden unexplained death associated with quinine, chloroquine or amodiaquine,
although each drug causes QT/QTc interval prolongation."


(reference page 36, Conclusions and Recommendations, of the WHO's paper entitled, "The cardiotoxicity of antimalarials.")

who.int

Best wishes,

I2